Expression and influence of pentraxin-3, HbAlc and ApoA1/ApoB in serum of patients with acute myocardial infarction combined with diabetes mellitus type 2

Zhu,Yanxia; Wang,Xiaofang; Wang,Weihua; Wang,Hongguang; Zhang,Fenglei

doi:10.3892/etm.2018.5930

Expression and influence of pentraxin-3, HbAlc and ApoA1/ApoB in serum of patients with acute myocardial infarction combined with diabetes mellitus type 2

Authors:
- Yanxia Zhu
- Xiaofang Wang
- Weihua Wang
- Hongguang Wang
- Fenglei Zhang
View Affiliations

Affiliations: Department of Cardiology, People's Hospital of Dongying, Dongying, Shandong 257091, P.R. China, Department of Emergency, People's Hospital of Dongying, Dongying, Shandong 257091, P.R. China
Published online on: March 6, 2018 https://doi.org/10.3892/etm.2018.5930
Pages: 4395-4399
Copyright: © Zhu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study investigated the clinical significance of changes in levels of hypersensitive plasma pentraxin-3 (PTX3), hemoglobin A1c (HbAlc) and apolipoprotein A-I (ApoA1)/apolipoprotein B (ApoB) on patients with acute myocardial infarction (AMI) and diabetes mellitus type 2 (T2DM). After admission, 100 patients diagnosed with AMI combined with T2DM were selected as Group A. According to the level of fasting blood glucose (FBG), they were then subdivided into Group A1 (n=44) with FBG ≥13.0 mmol/l and Group A2 (n=56) with FBG <13.0 mmol/l. A total of 100 hospitalized patients with AMI in People's Hospital of Dongying (Dongying, China) were collected as Group B, and 100 healthy people receiving physical examination in the Physical Examination Center of People's Hospital of Dongying were selected as Group C. Serum PTX3, HbAlc and ApoA1/ApoB of all the study participants were tested, and diseased coronary artery vessels were divided into single-, double- and triple-vessel lesions according to their numbers. Logistic regression analysis was performed for the number of diseased coronary artery vessels and each index. The level of PTX3 in Group A1 was higher than that in Group A2; the level of ApoA1/ApoB in the former was lower than that in the latter (p<0.05); and the level of HbAlc in the former was significantly higher than that in the latter (p<0.01); the levels of PTX3 and HbA1c in Group A2 were higher than those in Group B, while the level of ApoA1/ApoB in the former was lower than that in the latter (p<0.05). Logistic regression analysis showed that the number of diseased coronary artery vessels was positively correlated with PTX3 and HbA1c, but negatively correlated with ApoA1/ApoB. PTX3, HbAlc and ApoA1/apoB have a certain clinical significance in assessing the severity of AMI combined with T2DM.

View Figures

View References

1	Tillmann T, Vaucher J, Okbay A, Pikhart H, Peasey A, Kubinova R, Pajak A, Tamosiunas A, Malyutina S, Hartwig FP, et al: Education and coronary heart disease: Mendelian randomisation study. BMJ. 358:j35422017. View Article : Google Scholar : PubMed/NCBI
2	Gilani N, Kazemnejad A, Zayeri F, Hadaegh F, Azizi F and Khalili D: Anthropometric indices as predictors of coronary heart disease risk: Joint modeling of longitudinal measurements and time to event. Iran J Public Health. 46:1546–1554. 2017.PubMed/NCBI
3	Chen L, Wei B, Xu L and Wu Y: The association of inflammatory markers and periodontal indexes with the risk of coronary heart disease in Chinese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract. 135:37–44. 2017. View Article : Google Scholar : PubMed/NCBI
4	Kang HC and Hong JS: Association between costs and quality of acute myocardial infarction care hospitals under the Korea National Health Insurance program. Medicine (Baltimore). 96:e76222017. View Article : Google Scholar : PubMed/NCBI
5	Yavuz B, Kabakci G, Aksoy H, Tulumen E, Deveci OS, Aytemir K, Tokgozoglu L, Ozkutlu H, Nazli N and Oto A: Determining the relationship between metabolic syndrome score and angiographic severity of coronary artery disease. Int J Clin Pract. 62:717–722. 2008. View Article : Google Scholar : PubMed/NCBI
6	Wang J, Wu X, Li Y, Han X, Hu H, Wang F, Yu C, Li X, Yang K, Yuan J, et al: Serum bilirubin concentrations and incident coronary heart disease risk among patients with type 2 diabetes: The Dongfeng-Tongji cohort. Acta Diabetol. 54:257–264. 2017. View Article : Google Scholar : PubMed/NCBI
7	Farrokhian A, Bahmani F, Taghizadeh M, Mirhashemi SM, Aarabi MH, Raygan F, Aghadavod E and Asemi Z: Selenium supplementation affects insulin resistance and serum hs-CRP in patients with type 2 diabetes and coronary heart disease. Horm Metab Res. 48:263–268. 2016. View Article : Google Scholar : PubMed/NCBI
8	Ahmad S, Xue Z, Silverman A and Lindsay J: Complexity of the relation between hemoglobin A1C, diabetes mellitus, and progression of coronary narrowing in postmenopausal women. Am J Cardiol. 111:793–799. 2013. View Article : Google Scholar : PubMed/NCBI
9	Zhang J, Koussih L, Shan L, Halayko AJ, Chen BK and Gounni AS: TNF up-regulates Pentraxin3 expression in human airway smooth muscle cells via JNK and ERK1/2 MAPK pathways. Allergy Asthma Clin Immunol. 11:372015. View Article : Google Scholar : PubMed/NCBI
10	Lu M, Lu Q, Zhang Y and Tian G: ApoB/apoA1 is an effective predictor of coronary heart disease risk in overweight and obesity. J Biomed Res. 25:266–273. 2011. View Article : Google Scholar : PubMed/NCBI
11	Claesson R, Ekelund M, Ignell C and Berntorp K: Role of HbA1c in post-partum screening of women with gestational diabetes mellitus. J Clin Transl Endocrinol. 2:21–25. 2014. View Article : Google Scholar : PubMed/NCBI
12	National standards of P.R.C. Diagnostic Criteria of Coronary Atherosclerotic Heart Disease. Beijing: Quality Inspection Press of China 1–4; 2010
13	Deckers JG, Schellevis FG and Fleming DM: WHO diagnostic criteria as a validation tool for the diagnosis of diabetes mellitus: A study in five European countries. Eur J Gen Pract. 12:108–113. 2006. View Article : Google Scholar : PubMed/NCBI
14	de Kreutzenberg Vigili S, Solini A, Vitolo E, Boi A, Bacci S, Cocozza S, Nappo R, Rivellese A, Avogaro A and Baroni MG: Silent coronary heart disease in patients with type 2 diabetes: Application of a screening approach in a follow-up study. J Diabetes Complications. 31:952–957. 2017. View Article : Google Scholar : PubMed/NCBI
15	Emdin CA, Klarin D, Natarajan P, Florez JC, Kathiresan S and Khera AV and Khera AV: CARDIOGRAM Exome Consortium: Genetic variation at the sulfonylurea receptor, type 2 diabetes, and coronary heart disease. Diabetes. 66:2310–2315. 2017. View Article : Google Scholar : PubMed/NCBI
16	Naito A, Tanabe N, Jujo T, Shigeta A, Sugiura T, Sakao S, Ishida K and Tatsumi K: Pentraxin3 in chronic thromboembolic pulmonary hypertension: A new biomarker for screening from remitted pulmonary thromboembolism. PLoS One. 9:e1130862014. View Article : Google Scholar : PubMed/NCBI
17	Tarantino U, Feola M, Celi M and Scimeca M: PTX3: A new mediator of bone metabolism and osteoporosis. Muscles Ligaments Tendons J. 7:200–201. 2017. View Article : Google Scholar : PubMed/NCBI
18	Ohde S, Deshpande GA, Yokomichi H, Takahashi O, Fukui T and Yamagata Z: HbA1c monitoring interval in patients on treatment for stable type 2 diabetes. A ten-year retrospective, open cohort study. Diabetes Res Clin Pract. 135:166–171. 2018. View Article : Google Scholar : PubMed/NCBI
19	Hansel B, Giral P, Gambotti L, Lafourcade A, Peres G, Filipecki C, Kadouch D, Hartemann A, Oppert JM, Bruckert E, et al: A fully automated web-based program improves lifestyle habits and HbA1c in patients with type 2 diabetes and abdominal obesity: Randomized trial of patient E-coaching nutritional support (The ANODE Study). J Med Internet Res. 19:e3602017. View Article : Google Scholar : PubMed/NCBI
20	Mousavi SN, Kamali K, Mirbazel M and Jameshorani M, Mousavi N, Kamali K, Mirbazel M and Jameshorani M: The best cut-off value for HbA1c as a screening tool in Iranian women with gestational diabetes mellitus. J Family Reprod Health. 11:37–42. 2017.PubMed/NCBI
21	Jiang J, Zhao L, Lin L, Gui M, Aleteng Q, Wu B, Wang S, Pan B, Ling Y and Gao X: Postprandial blood glucose outweighs fasting blood glucose and HbA1c in screening coronary heart disease. Sci Rep. 7:142122017. View Article : Google Scholar : PubMed/NCBI
22	Trivedi H, Gray LJ, Seidu S, Davies MJ, Charpentier G, Lindblad U, Kellner C, Nolan J, Pazderska A, Rutten G, et al: Self-knowledge of HbA1c in people with type 2 diabetes mellitus and its association with glycaemic control. Prim Care Diabetes. 11:414–420. 2017. View Article : Google Scholar : PubMed/NCBI
23	Bays HE, Shah A, Lin J, Sisk CM, Dong Q and Maccubbin D: Consistency of extended-release niacin/laropiprant effects on Lp(a), ApoB, non-HDL-C, Apo A1, and ApoB/ApoA1 ratio across patient subgroups. Am J Cardiovasc Drugs. 12:197–206. 2012. View Article : Google Scholar : PubMed/NCBI
24	Zheng J, Yin Q, Cao J and Zhang B: Obesity contributes more to increasing ApoB/ApoA1 ratio than hyperandrogenism in PCOS women aged 20–38 years in China. Exp Ther Med. 13:1337–1342. 2017. View Article : Google Scholar : PubMed/NCBI
25	Öhman M, Öhman ML and Wållberg-Jonsson S: The apoB/apoA1 ratio predicts future cardiovascular events in patients with rheumatoid arthritis. Scand J Rheumatol. 43:259–264. 2014. View Article : Google Scholar : PubMed/NCBI